Suzanne Maahs

Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual‐Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi)

Jessie Gu, Adele Noè, Priya Chandra et al. · The Journal of Clinical Pharmacology · 2009 · 502 citations

Medicine, Pharmacokinetics, Pharmacology +17

Pharmacokinetics, pharmacodynamics and safety of <scp>QGE</scp>031 (ligelizumab), a novel high‐affinity anti‐IgE antibody, in atopic subjects

Jonathan Arnold A. P., I. Bottoli, Andrej Skerjanec et al. · Clinical & Experimental Allergy · 2014 · 241 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +17

Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses

Gail M. Gauvreau, Louis‐Philippe Boulet, Richard Leigh et al. · Journal of Allergy and Clinical Immunology · 2016 · 135 citations · Full text

Life Sciences, Immunology, Pharmacology +15

Mobilise-D insights to estimate real-world walking speed in multiple conditions with a wearable device

Cameron Kirk, Arne Küderle, M. Encarna Micó-Amigo et al. · Scientific Reports · 2024 · 71 citations · Full text

Education, Physical Medicine, Movement Analysis +16

Safety and Exploratory Efficacy Of Ex Vivo Expanded Umbilical Cord Blood (UCB) Hematopoietic Stem and Progenitor Cells (HSPC) Using Cytokines and Stem-Regenin 1 (SR1): Interim Results Of a Phase 1/2 Dose Escalation Clinical Study

John E. Wagner, Claudio G. Brunstein, David H. McKenna et al. · Blood · 2013 · 15 citations

Medicine, Biomedical Sciences, Hematology +17